Many poor people in developing countries do not have access to the drugs they need. Often they can not afford them. But cheap is not everything when it comes to making the drug more accessible.
sell all drugs for everyone with prices of production they will not work in the long run
To make affordable drugs in developing countries, pharmaceutical companies charge their customers in Europe and the United States far more than decent drugs. Instead, they sell the same substance at lower prices in poor countries
The same vaccine, for example, will be sold at 50 euros ($ 68) in the United States or in Europe and for three to four euros in Africa, "said Bompart." Whole system works because in the middle you have countries like Brazil, South Africa and Thailand are paid 10 to 20 euros. "
The new generation of HIV drugs are very expensive.
Tiered pricing failed, though, when it comes to many tropical diseases that affects only poor people in low-income countries, such as sleeping sickness. Here, a partnership between non-governmental organizations, governments and pharmaceutical companies is the only way to develop and produce drugs save lives.
In the case of malaria, pharmaceutical company GlaxoSmithKline in collaboration with eleven African research centers to develop a vaccine against malaria for children. The Bill and Melinda Gates Foundation supported the study financially.
drug financing
Even cheaper drugs may be too expensive if the money was not there. Therefore, the key to make the drug more accessible is health financing system,
Success in India
In India, the German Society for International Cooperation (GIZ) to assist the government in setting up a system that allows poor families to receive free treatment at the hospital. For each patient, the government will pay up to 30,000 Indian rupees (around 340 euros) per year.
The government distributed electronic smartcard for the poorest families in the country so that the patient knows the hospital is part of the program, which began in 2008.
Hospitals in India
Very poor people can now get free treatment in many hospitals of India.
Education is more important than drugs?
Medications are an important part of health care, but not the most important in many situations,
Blood samples indicate if a person is infected with malaria - but health professionals must have the skills to diagnose disease
One of the diseases are often treated epilepsy. Chronic neurological disease affecting 50 million people worldwide, and 90 percent of them live in developing countries. The patients suffered from recurrent epileptic seizure due to abnormal brain activity. Pharmacy can suppress seizures but WHO estimates that in developing countries, three-quarters of people with epilepsy do not receive the care they need.
If people with epilepsy are not treated these days, it's not because the drug is expensive, it's because patients are not diagnosed properly,
 |
|
In some cultures people believe that epilepsy patients destined, even trance. Many families feel embarrassed to bring their children to health professionals epilepsy and, on the contrary, they hide inside. In this case, combat stigma by educating the public about the medical causes of epilepsy is the first step in improving access to medicines.
Read more ...
If there is a way to get the immune system to recognize tumor cells as a threat, it will fight them.
Projekt Zukunft Immune One of the features that distinguish cancer cells from healthy ones is a special structure on the outer wall of each cell tumor composed of protein molecules called peptides.
If the immune system can learn to sniff these molecules, will attack cancer cells and may even destroy them. Researchers at the University Clinic Tübingen have successfully mapped the precise structure of a particular peptide. They use this information to synthesize protein molecules and produce a vaccine from it. So far, they have cataloged nearly one million different peptides. Every cancer survivor has a unique combination of them. As things stand, it is very expensive to make this peptide cocktail for each patient. But the researchers hope their findings will soon find their way into practical treatments.
Read more ...
Lars Zender at the University Hospital in Tübingen has studied how new ways to treat liver and colon cancer. He investigates how cells into tumor cells and under what conditions the immune system can prevent it.
With approximately ten other scientists with Zender in 2014 Leibniz Prize from the German Research Foundation. This award, the most important prize is considered the German research funding endowed with a total of 2.5 million euros.
Read more ...
With the new technology, computer users can immediately understand better by reading their minds. What sounds like science fiction already passed the first test of the real world - in a flight simulator.
The pilot sits in a flight simulator wearing the EEG cap.
While there is much more to fly than the wheel, sitting in the flight simulator pilot wearing the EEG cap (electrode-studded cap that reads brain activity) was recently able to steer the aircraft flight path free hands - just by imagining a joystick in their mind's eye. Quite predictably, this whipped up more than its fair share of media stories about "science fiction-style thought control." However, application of this technology is decades away - and even then, it was really only intended for pilots defect.
Each of the five groups involved in the research project funded by the European Union Brainflight have different goals with faster application.
Getting the public interest
Fricke does not recognize,
however,
that the press release Brainflight played up sci-fi
scenario deliberately.
A lot of research has gone into Brainflight before the action plane,
but laboratory experiments are not sexy enough to spur media coverage,
according to Fricke.
The human brain can be immediately read by the computer
Although it may not be quite striking to reporters today,
the technology developed by Fricke and his colleagues have great potential.
This can make working on a computer is much easier - by providing PC access to the thoughts and feelings through a brain-computer
interface (BCI).
A computer does not record user frustration when something is not working properly,
or impatience when a program takes too long to get started - yet.
This technology could resemble a smart version of Clippy,
the animated paper clip from Microsoft Office programs. Clippy will always appear at the most inopportune time and then it just will not go away.
A computer with a kind of emotional intelligence can see when the user needs help and only then send Clippy bounced off the screen.
Read more ...
A team of German scientists have come up with new luminescent materials for LED lamps. Phosphorus improve energy efficiency and create artificial light is almost as natural as the sun.
Wolfgang Schnick knows a thing or two about the quality of light. Not only has the German chemist examined the luminescent material since 2001 - but the shopping expedition with his wife has taught him first hand the difference between a good and bad light.
You may have experienced it as well.
The lights in the store could be so distorted that blue dress can appear black.
has developed a new luminophore - a chemical compound used in the luminescence.
change the color of the light emitted by the LED (light emitting diodes)
in such a way that they believe has "the potential to
revolutionize the LED market."
Mixing bright colors
Since incandescent lamps were ordered from the EU market in 2012,
LED lighting has been endorsed as the best alternative.
They are popular because they do not like energy-saving light,
LED light up instantly,
without the heating phase,
and they contain virtually no toxic materials.
The problem is the usual LEDs emit only one color.
But that's not how we want to experience light in everyday situations.
When we read a book on a dark afternoon or see ourselves in the bathroom mirror first thing in the morning,
we expect white light - and the white light is a mixture of many colors.
It is possible to achieve this with LEDs by covering them with a luminescent material.
For white light,
an amber-colored
luminophore is usually applied to blue LEDs.
It is the same principle as applying crepe paper for light to get the red or blue light luxury.
A few years ago,
the team collaborated with Philips Lumileds Schnick Development Center to develop these materials not only for the LED.
It is still on the market,
which are used in LED lights are made by the parent company's
development center,
Philips.
better efficiency
The new luminophore also promised to create a more efficient LED light.
LED lights are currently using luminescent materials that add too much red to light.
The resulting wavelength is similar to infrared light,
the one that the human eye can not fully process.
And we can not light the light we can not "see"
- and a waste of energy.
Scientists say a new luminescent material they fix this problem.
It adds less red color to mix and as a result, the LED lights are up to 14 percent more energy efficient than current ones.
Cardiologist at Düsseldorf University Hospital said that they had
become the first in the world to use stem cell therapy to save a patient who suffered a severe heart attack.
Düsseldorf newspaper Rheinische Post reported the story of the success of stem cell therapy in patients 64 years of age.
Bodo-Eckehard Stauer, director of the department of cardiology at the University Hospital Düsseldorf, told the Rheinische Post that the patient was "on the verge of dying" after suffering a severe heart attack. The man spent seven weeks in the intensive care unit with no signs of improvement.
Stauer decided to apply stem cell therapy in patients. After nine days of treatment, he had improved enough that he could leave intensive care and transferred to a rehabilitation center.
This therapy involves extraction of adult stem cells from the bone marrow of patients and then insert them, with the help of a balloon catheter, into an artery damaged by infarction.
This procedure takes about half an hour.
Stauer called it a "global innovation" in cardiogenic shock - inadequate delivery of oxygen to the heart tissue - can be treated with stem cell therapy for the first time.
Embryonic stem cell research is banned in Germany
The stem cell therapy, however, has enlivened the debate about embryonic stem cell research.
More recently, the German government said it would allocate € 5 million ($ 6.9 million) over the next three years to research non-embryonic stem cells.
Stem cells can develop into different cell types, including bone, blood and brain. Specialists say that they can help in treating diseases such as Parkinson's, and can help to regenerate damaged organs or tissue.
The researchers say embryonic stem cells - cells taken from human embryos-days old - the most promising.
Woman in a car suffering from a heart attack
Mild heart attack often go unnoticed
However, genetic studies strongly opposed in Germany because of the history of Nazi experiments to create a superior race.
Since 2002, the production of cells of the embryonic stem cell lines that already exist previously banned in Germany. Scientists are also not allowed to research on each line produced after January 1, 2002 to ensure that foreign laboratories do not make a new path for the German market.
Critics say the ban put German scientists at a disadvantage.
Critics of embryonic stem cell research, however, said that the progress of the treatment of adult stem cells, such as the patient's heart in Düsseldorf, canceling the need of cells derived from human embryos.
